Allspring Global Investments Holdings LLC Has $68.69 Million Stock Holdings in Tenet Healthcare Corporation $THC

Allspring Global Investments Holdings LLC reduced its stake in Tenet Healthcare Corporation (NYSE:THC) by 14.9% during the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 344,388 shares of the company’s stock after selling 60,184 shares during the period. Allspring Global Investments Holdings LLC owned 0.39% of Tenet Healthcare worth $68,688,000 at the end of the most recent quarter.

A number of other hedge funds also recently modified their holdings of THC. Triumph Capital Management acquired a new position in Tenet Healthcare in the 3rd quarter valued at about $25,000. William B. Walkup & Associates Inc. acquired a new position in shares of Tenet Healthcare in the third quarter valued at approximately $32,000. Westside Investment Management Inc. increased its stake in shares of Tenet Healthcare by 100.0% during the third quarter. Westside Investment Management Inc. now owns 192 shares of the company’s stock worth $39,000 after purchasing an additional 96 shares during the period. Trust Co. of Vermont acquired a new stake in Tenet Healthcare during the 3rd quarter worth approximately $41,000. Finally, Canada Pension Plan Investment Board bought a new stake in Tenet Healthcare in the 2nd quarter valued at $35,000. Institutional investors and hedge funds own 95.44% of the company’s stock.

Wall Street Analysts Forecast Growth

A number of equities research analysts have recently weighed in on the company. UBS Group lifted their target price on Tenet Healthcare from $260.00 to $288.00 and gave the stock a “buy” rating in a report on Thursday, February 12th. Truist Financial raised their price target on shares of Tenet Healthcare from $240.00 to $270.00 and gave the stock a “buy” rating in a research report on Tuesday, February 17th. Guggenheim boosted their price objective on shares of Tenet Healthcare from $271.00 to $283.00 and gave the company a “buy” rating in a report on Thursday, March 12th. Jefferies Financial Group raised their target price on shares of Tenet Healthcare from $250.00 to $265.00 and gave the stock a “buy” rating in a report on Thursday, February 12th. Finally, Wells Fargo & Company reiterated an “overweight” rating and issued a $265.00 price target on shares of Tenet Healthcare in a research note on Monday, February 16th. One analyst has rated the stock with a Strong Buy rating, eighteen have given a Buy rating and three have assigned a Hold rating to the company’s stock. According to MarketBeat, Tenet Healthcare presently has an average rating of “Moderate Buy” and a consensus price target of $250.56.

Tenet Healthcare Price Performance

THC stock opened at $188.56 on Wednesday. The company’s 50-day moving average price is $213.53 and its two-hundred day moving average price is $205.21. Tenet Healthcare Corporation has a 12 month low of $109.82 and a 12 month high of $247.21. The company has a quick ratio of 1.68, a current ratio of 1.76 and a debt-to-equity ratio of 2.18. The firm has a market cap of $16.40 billion, a P/E ratio of 12.17, a P/E/G ratio of 0.91 and a beta of 1.39.

Tenet Healthcare (NYSE:THC) last posted its quarterly earnings results on Wednesday, February 11th. The company reported $4.70 earnings per share (EPS) for the quarter, topping the consensus estimate of $4.08 by $0.62. Tenet Healthcare had a net margin of 6.60% and a return on equity of 26.33%. The business had revenue of $5.53 billion for the quarter, compared to analyst estimates of $5.47 billion. During the same quarter last year, the business posted $3.44 EPS. The firm’s revenue for the quarter was up 8.9% on a year-over-year basis. Tenet Healthcare has set its FY 2026 guidance at 16.190-18.470 EPS. On average, analysts anticipate that Tenet Healthcare Corporation will post 12.24 earnings per share for the current fiscal year.

Insider Transactions at Tenet Healthcare

In related news, insider R. Scott Ramsey sold 8,017 shares of the company’s stock in a transaction on Monday, March 2nd. The stock was sold at an average price of $232.70, for a total transaction of $1,865,555.90. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. Also, EVP Thomas W. Arnst sold 24,000 shares of Tenet Healthcare stock in a transaction dated Monday, March 2nd. The shares were sold at an average price of $234.04, for a total value of $5,616,960.00. Following the completion of the transaction, the executive vice president owned 8,012 shares in the company, valued at approximately $1,875,128.48. This represents a 74.97% decrease in their position. The disclosure for this sale is available in the SEC filing. In the last quarter, insiders sold 46,517 shares of company stock valued at $10,943,111. Corporate insiders own 0.81% of the company’s stock.

Tenet Healthcare Profile

Tenet Healthcare Corporation (NYSE: THC) is a diversified American healthcare services company that owns and operates acute care hospitals and a broad range of outpatient facilities. Its portfolio includes general acute-care hospitals, specialty hospitals, ambulatory surgery centers, urgent care and diagnostic imaging centers, and other ancillary service locations. Tenet’s operations are oriented around delivering inpatient and outpatient clinical care across multiple medical specialties, with an emphasis on surgical services, emergency care, and advanced diagnostics.

In addition to facility-based care, Tenet provides integrated services designed to support clinical operations and improve patient access and care coordination.